Latest Menopause Stories

Connie K. Ho for redOrbit.com – Your Universe Online While some people believe that hypnosis is just for fun and games, new research reports that clinical hypnosis is effective in helping menopausal females. A new study by scientists at Baylor University’s Mind-Body Medicine Research Laboratory recently revealed that clinical hypnosis can help decrease the occurrence of hot flashes and other related symptoms following menopause for women. The scientists tracked the physical symptoms...

A new study suggests that women who begin taking hormone therapy within five years of menopause may reduce their risk of developing Alzheimer's disease. The research is published in the October 24, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology. "This has been an area of debate because observational studies have shown a reduced risk of Alzheimer's disease with hormone therapy use, while a randomized controlled trial showed an increased risk. Our...

Hypnosis can help cut hot flashes by as much as 74%, shows a study supported by the National Center for Complementary and Alternative Medicine. This is the first controlled, randomized study of the technique to manage hot flashes, which affect as much as 80% of women who go through menopause. The study was published online this month in Menopause, the journal of the North American Menopause Society. Controlled, randomized studies may pit an active drug against an inactive placebo pill. But...

Lawrence LeBlond for redOrbit.com - Your Universe Online Our grandmothers being there to care of us is something we all take for granted, and we have our ancestors to thank for that. New research indicates that human longevity is what it is because of grandmothers helping with childcare at an early stage in human history. Computer simulations on evolution have helped scientists prove that humans evolved longer life spans than apes because of their grandmotherly duties. When it comes to...

Connie K. Ho for redOrbit.com – Your Universe Online While phrases like “I love Big Bird” and “binders full of woman” are tidbits that people remember about the past two presidential candidate debates, another facet of the debates is the clothing that the spouses of the presidential candidates wear. In this past week’s debate, both Michelle Obama and Ann Romney chose to wear the striking color of pink. The color reflects October as breast cancer awareness month. While awareness...

MINNEAPOLIS and PHILADELPHIA, Oct. 16, 2012 /PRNewswire/ -- Tarsa Therapeutics, Inc. today announced that a Phase II trial of its oral recombinant salmon calcitonin in the prevention of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, clinically relevant improvements in bone mineral density (BMD) at the lumbar spine. These data were presented at the American Society for Bone and Mineral Research (ASBMR) 2012 Annual Meeting by Phase II...

BOONTON, N.J., Oct. 15, 2012 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that its successful Phase 2 clinical trial evaluating an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women was the subject of an oral presentation given by Morten Karsdal, MSc, PhD, Chief Executive Officer of Nordic Bioscience, at...

MENLO PARK, Calif., Oct. 15, 2012 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that its New Drug Application (NDA) for Serada® has been accepted for filing by the U.S. Food and Drug Administration (FDA). In addition, the FDA has informed the company that the FDA's Reproductive Health Drugs Advisory Committee will discuss the Serada NDA at an Advisory Committee meeting tentatively scheduled for March 4, 2013. The NDA will be subject to a standard review and will have...

THOUSAND OAKS, Calif., Oct. 14, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has presented data from several Prolia(®) (denosumab) studies, including data from the open-label extension study of the pivotal Phase 3 fracture trial, which showed continued increases in bone mineral density (BMD) and low fracture incidence over six years. These data, and those from several key studies, were presented at the American Society for Bone and Mineral Research (ASBMR) 2012...

Lee Rannals for redOrbit.com - Your Universe Online According to a study published in the journal BMJ, taking hormone replacement therapy (HRT) may reduce the risk of developing heart problems. The researchers found that HRT is not associated with an increased risk of cancer or stroke as several previous studies have claimed, and it also may help reduce the risk of heart attacks. The team followed 1,000 women over 10 years, half of which were on HRTs. Women who took part in the study...